- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RadNet earnings slip, volume rises
Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008.
Revenues edged up 2% for Radnet in the third quarter over the year earlier period, but the national provider of outpatient diagnostic imaging services recorded a loss in the quarter compared to positive earnings in 3Q 2008. For the three months ended Sept. 30, 2009, RadNet reported revenue of $133.4 million versus $130.9 million in 3Q 2008 and a loss of $1.7 million compared with net income of $138,000. On a same-center basis, including only centers that were part of RadNet for both the third quarters of 2009 and 2008, MRI volume increased 5.4%, CT volume increased 4.0%, and PET/CT volume increased 4.3%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 3.2% over the same quarter in the prior year.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
